1 completed, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Completed 1, Withdrawn 1 |
Follow Hemophilia: new trials by email Literature Review of Hemophilia trials Research Report on Hemophilia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical and Local TXA in Facelifts - A Randomized Controlled Double Blinded Study 1%Tranexamic acid with standard local, 3% TXA, 1% TXA with local plus 3% TXA-soaked pledgets - Hemophilia, Hemorrhage | Early Phase 1 | Withdrawn | University of Minnesota | 2024-07-01 | 2026-07-23 | |
| Extended Half Life Factor (EHF) Products For Heavy Menstrual Bleeding in Hemophilia Carriers Recombinant FVIII Fc fusion product Eloctate, Recombinant FIX Fc fusion product Alprolix, Patient-operated diagnostic device for anemia AnemoCheck. - Hemophilia, Menstrual Flow Excessive | Early Phase 1 | Completed | Emory University | 3 | 2018-02-14 | 2020-05-18 |
Hemophilia A (2) · Hemorrhage (1) · Menorrhagia (1)
Blood Coagulation Disorders (2) · Blood Coagulation Disorders, Inherited (2) · Coagulation Protein Disorders (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Hemorrhage (1)
factor IX Fc fusion protein (1) · factor VIII-Fc fusion protein (1)
Emory University (1) · University of Minnesota (1)
United States (2)
Friederike Luetzenberg,, MD (1) · Jenna Van Beck, MD (1) · Robert Sidonio, MD, MSc (1)